申请人:Eli Lilly and Company
公开号:US04029671A1
公开(公告)日:1977-06-14
There are disclosed novel 3-[(5-nitro-2-imidazolyl)pyrazol-5-yl]oxamic acid derivatives and salts thereof, exhibiting utility as antibacterial, antiprotozoal, and antifungal agents, making the compounds useful particularly in veterinary medicine, especially in controlling bacterial and protozoal infections of cattle, swine, and poultry.
本发明揭示了新型的3-[(5-硝基-2-咪唑基)吡唑-5-基]氧化酰胺衍生物及其盐,具有作为抗菌、抗原虫和抗真菌剂的效用,使得这些化合物在兽医学中特别有用,尤其是在控制牛、猪和家禽的细菌和原虫感染方面。